Latigo Biotherapeutics Inc. has synthesized sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers. They are reported to be useful for the treatment of pain, cough and pruritus.
The Global Ventricular Tachycardia Market is estimated to be valued at USD 15.52 Bn in 2025 and is expected to reach USD 22.28 Bn by 2032, reflecting a compound annual growth rate (CAGR) of 5.3% from ...
Woman's World on MSN
Is your BP pill making you tired? This MD shares what to avoid
"The main side effect is them not working! Not everyone responds to every drug." The common blood pressure drug you may want ...
Topline results from the ASPIRE Phase 2b study expected in mid-2026 with operating runway through 2027Series B extension was led by Arkin Bio Capital and Monograph Capital, with participation from ...
Jumpcan Pharmaceutical Group Ltd. has divulged sodium channel protein type 10 subunit α (SCN10A; Nav1.8) blockers reported to be useful for the treatment of pain.
SaveHealth reports on 10 hypertension medications, their classifications, effectiveness, side effects, and safety in managing high blood pressure.
Long QT syndrome is a leading cause of sudden death in young persons, with a prevalence exceeding 1 in 2000. It is characterized by prolongation of the QT interval, aberrant T-wave morphologic ...
Internal Medicine Department of Hospital Santa Maria Maior, Unidade Local de Saúde Barcelos/Esposende, Braga, Portugal. Lamotrigine is an antiepileptic medication that functions primarily as a voltage ...
I deem today’s topic, a new medication for acute pain, so important that I believe would be remiss if I did not write about it. A link to this article will be included in this email.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback